Results 111 to 120 of about 11,293 (160)

Cerebello-Brainstem Dominant Form of X-linked Adrenoleukodystrophy Without Apparent Brain MRI Abnormalities at Disease Onset. [PDF]

Cerebellum
Nakagawa Y, Sugiyama A, Shibuya K, Yokota H, Matsukawa T, Ishiwata K, Mori M.   +6 more
europepmc   +1 more source

The Status and Future Directions of Treatments for Polyglutamine Spinocerebellar Ataxia: A Bibliometric and Visual Analysis. [PDF]

Curr Neuropharmacol
Ding S, Peng L, Chen Z, Dong M, Tang C, Gong Y, He L, Wu Q, Qiu R, Jiang H.   +9 more
europepmc   +1 more source

Establishment of a second-generation transgenic marmoset with germline transmission that models polyglutamine disease

Disease Models & Mechanisms
Eiko N. Minakawa, Kensuke Owari, Naotake Nogami, Terumi Nakatani, Masashi Koizumi, Akiyo Kawanobe, Yosuke Saga, Moeko Kudo, Satoru Noguchi, Takashi Hanakawa, Yuki Hori, Hidemi Numazawa, Toshihide Takeuchi, Yuko Katakai, Ryoichi Saito, Yoshitaka Nagai, Yuko Saito, Ikuo Tomioka, Kazuhiko Seki   +18 more
doaj   +1 more source

Lipid Composition Drives Mutant Huntingtin Dimerization and Membrane Association: Insights from Computational Simulations. [PDF]

Molecules
Nicoara C, Criscuolo E, De Cristofaro A, Fezza F, Maccarrone M.   +4 more
europepmc   +1 more source

Hypothalamic Atrophy and Textural Changes in Polyglutamine Ataxias. [PDF]

Cerebellum
Rodrigues L, Rezende TJR, Martinez ARM, Massuyama B, Pedroso JL, Barsottini OGP, Iglesias JE, Appenzeller S, Rittner L, França MC.   +9 more
europepmc   +1 more source

The Hsp40 cochaperone DNAJC7 regulates polyglutamine aggregation and exhibits context-dependent effects on polyglycine aggregation. [PDF]

J Biol Chem
Ramani B, Ehsani K, Kampmann M.
europepmc   +1 more source

Polyglutamine-Expanded Ataxin-3 Accelerates CFTR Degradation Through K63-Linked Ubiquitination to Exacerbate Microglial Inflammation. [PDF]

ASN Neuro
Wang Z, Fan X, Bai B, Song M, Shi Y, Zhao Y, Xie P, Shi T, He C, Hu Y, Wu Q, Hou X.   +11 more
europepmc   +1 more source

Targeting UCHL3 attenuates pathological markers in neuronal models of Huntington's disease. [PDF]

Brain
Ishtayeh H, Battistoni E, Pochtar S, McHugh TLM, Tshilenge KT, Rossmiller B, Amer-Sarsour F, Berdichevsky Y, Muchtar N, Weil M, Ellerby LM, Ashkenazi A.   +11 more
europepmc   +1 more source

CAG-targeting artificial miRNA with reduced off-target risk for efficient lowering of pathogenic polyglutamine proteins. [PDF]

NAR Mol Med
Pewinska-Kolodziejczak M, Kotowska-Zimmer A, Przybyl L, Wronka D, Karlik A, Smuszkiewicz M, Balcerek J, Suszynska-Zajczyk J, Piaszyk-Borychowska A, Urbanek-Trzeciak M, Sablok G, Kozlowska E, Podkowinski J, Fiszer A, Kozlowski P, Handschuh L, Olejniczak M.   +16 more
europepmc   +1 more source

Dynamics of autophagy in response to high linear energy transfer radiation and cancer. [PDF]

Korean J Clin Oncol
Lal M.
europepmc   +1 more source